| Autophagy in cancer metastasis EE Mowers, MN Sharifi, KF Macleod Oncogene 36 (12), 1619-1630, 2017 | 462 | 2017 |
| Autophagy promotes focal adhesion disassembly and cell motility of metastatic tumor cells through the direct interaction of paxillin with LC3 MN Sharifi, EE Mowers, LE Drake, C Collier, H Chen, M Zamora, S Mui, ... Cell reports 15 (8), 1660-1672, 2016 | 326 | 2016 |
| Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis AH Chourasia, K Tracy, C Frankenberger, ML Boland, MN Sharifi, ... EMBO reports 16 (9), 1145-1163, 2015 | 301 | 2015 |
| Functions of autophagy in the tumor microenvironment and cancer metastasis EE Mowers, MN Sharifi, KF Macleod The FEBS journal 285 (10), 1751-1766, 2018 | 211 | 2018 |
| Measuring autophagy in stressed cells MN Sharifi, EE Mowers, LE Drake, KF Macleod Stress responses: methods and protocols, 129-150, 2015 | 89 | 2015 |
| Large‐scale insertional mutagenesis of Chlamydomonas supports phylogenomic functional prediction of photosynthetic genes and analysis of classical acetate … RM Dent, MN Sharifi, A Malnoë, C Haglund, RH Calderon, S Wakao, ... The Plant Journal 82 (2), 337-351, 2015 | 71 | 2015 |
| p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors WL Kuo, MN Sharifi, MW Lingen, O Ahmed, J Liu, M Nagilla, KF Macleod, ... PLoS One 9 (3), e90171, 2014 | 33 | 2014 |
| Mg chelatase in chlorophyll synthesis and retrograde signaling in Chlamydomonas reinhardtii: CHLI2 cannot substitute for CHLI1 P Brzezowski, MN Sharifi, RM Dent, MK Morhard, KK Niyogi, B Grimm Journal of Experimental Botany 67 (13), 3925-3938, 2016 | 31 | 2016 |
| Novel insights into how autophagy regulates tumor cell motility EE Mowers, MN Sharifi, KF Macleod Autophagy 12 (9), 1679-1680, 2016 | 29 | 2016 |
| Intragenic Enhancers and Suppressors of Phytoene Desaturase Mutations in Chlamydomonas reinhardtii PT Tran, MN Sharifi, S Poddar, RM Dent, KK Niyogi Public Library of Science 7 (8), e42196, 2012 | 27 | 2012 |
| Longitudinal molecular profiling of circulating tumor cells in metastatic renal cell carcinoma M Bootsma, RR McKay, H Emamekhoo, RM Bade, JL Schehr, ... Journal of Clinical Oncology 40 (31), 3633-3641, 2022 | 25 | 2022 |
| Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: resistance mechanisms and novel treatment strategies MN Sharifi, A Anandan, P Grogan, RM O’Regan Cancer 126 (15), 3400-3416, 2020 | 23 | 2020 |
| A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer SG Zhao, JM Sperger, JL Schehr, RR McKay, H Emamekhoo, A Singh, ... The Journal of Clinical Investigation 132 (21), 2022 | 12 | 2022 |
| A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782) TA Leal, MN Sharifi, N Chan, R Wesolowski, AA Turk, JY Bruce, ... Cancer medicine 11 (21), 3969-3981, 2022 | 11 | 2022 |
| Abstract OT1-02-01: Phase I trial of bicalutamide and ribociclib in androgen receptor-positive triple negative breast cancer M Sharifi, KB Wisinski, ME Burkard, AJ Tevaarwerk, D Tamkus, N Chan, ... Cancer Research 79 (4_Supplement), OT1-02-01-OT1-02-01, 2019 | 11 | 2019 |
| Fragmentomic analysis of circulating tumor DNA-targeted cancer panels KT Helzer, MN Sharifi, JM Sperger, Y Shi, M Annala, ML Bootsma, ... Annals of Oncology 34 (9), 813-825, 2023 | 7 | 2023 |
| Identification of phenocopies improves prediction of targeted therapy response over DNA mutations alone H Bakhtiar, KT Helzer, Y Park, Y Chen, NR Rydzewski, ML Bootsma, ... NPJ Genomic Medicine 7 (1), 58, 2022 | 5 | 2022 |
| HER2-positive breast cancer S Hurvitz, K McCann Elsevier Health Sciences, 2018 | 5 | 2018 |
| Autophagic degradation of focal adhesions underlies metastatic cancer dissemination MN Sharifi, EE Mowers, KF Macleod Molecular & Cellular Oncology 4 (2), e1198299, 2017 | 5 | 2017 |
| Molecular assays to determine optimal duration of adjuvant endocrine therapy in breast cancer A Anandan, M Sharifi, R O’Regan Current Treatment Options in Oncology 21, 1-8, 2020 | 4 | 2020 |
